AI assistant
Sending…
OnKure Therapeutics, Inc. — Director's Dealing 2021
Oct 14, 2021
34730_dirs_2021-10-14_f85990b6-4ff9-488e-9e09-9d7f375b4f8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Reneo Pharmaceuticals, Inc. (RPHM)
CIK: 0001637715
Period of Report: 2020-10-11
Reporting Person: Hall Ashley (Chief Development Officer)
More from OnKure Therapeutics, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Capital/Financing Update
2026
Apr 24
Capital/Financing Update
2026
Mar 30
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Jan 2
Director's Dealing
2026
Jan 2